Sign up for Health Research Trax – your research network provided by Western Alliance.Register Now

Dietary supplements: Should we take our vitamins?

The 2014–2015 National Health Survey found that over half of women and over a third of men in Australia, as well as about a quarter of children, had consumed at least one dietary supplement in the previous two weeks. Indeed, the sale of vitamins and other dietary supplements represents big business – estimated at $1.5 billion per year in Australia in 2013.

The pursuit of good health and longevity drives this substantial and rapidly increasing consumption of dietary supplements, but do they really help, or – as former Australian Medical Association president, Dr Michael Gannon, said – do they just create ‘very expensive urine’? (Dr Gannon also noted that ‘vitamins are useful for treating specific deficiencies’.)

In this article, we examine the research evidence for the effectiveness of some of the most common dietary supplements used by Australians. (Note that we looked at harms associated with use of complementary and alternative medicines, a category that includes some of the substances discussed here, in April 2016.)

Vitamin C

Vitamin C is an essential nutrient that promotes the growth and repair of human tissue, is an antioxidant and prevents scurvy. Interestingly, scurvy is a disease once thought eradicated in the Western world, but it has been documented in Australian and British people living with diabetes as recently as 2016.

Many common foods contain vitamin C, but many people consume it as a supplement to treat the common cold – a notion originally derived from dual Nobel prize-winner Linus Pauling’s advocacy of vitamin C supplementation in the early 1970s. However, the evidence for its effectiveness against the common cold is mixed.

A Cochrane review of 65 placebo-controlled trials examined two main questions: Does taking vitamin C reduce the risk of a cold? Does it reduce the duration of a cold? In a meta-analysis of 29 trials involving 11 306 participants, the reviewers found that
vitamin C did not reduce the number of colds significantly (relative risk (RR) = 0.97, 95 per cent confidence interval (CI) 0.94–1.00). However, after meta-analysis of a further 31 trials involving 9745 common cold episodes, they concluded that regularly supplementing the diet with 1 to 2 grams per day of vitamin C during illness reduced the duration of colds by an average of
8 per cent in adults and 14 per cent in children.

Interestingly, a meta-analysis of the remaining five trials, involving 598 marathon runners, skiers and soldiers in subarctic exercises, yielded a much stronger RR of 0.48 (95 per cent CI 0.35–0.64), suggesting that vitamin C consumption halved the risk of a cold in this group. The conclusion drawn from this sub-study was that vitamin C supplementation may be useful for people exposed to brief periods of severe physical exercise, and that further research is warranted.

Fish oil

Fish oil contains omega-3 essential fatty acids, which are widely believed to improve blood chemistry, reduce inflammation and boost the immune system, thereby improving overall health. However, a meta-analysis of 20 studies found no association between omega-3 supplementation and risk of cardiac arrest, heart attack, stroke or sudden death. Acting on this and other evidence, in 2015, the Heart Foundation’s recommendation for Australian adults to consume fish oil (by eating oily fish or taking supplements) was downgraded from daily to two to three times per week.

Increased consumption of fish oil has also been claimed to reduce the chance of developing dementia. However, a Cochrane review of three studies of cognitively healthy people over the age of 60 years (3536 participants), who were randomly assigned to receive gel capsules of fortified margarine containing omega-3s or placebos, showed no benefit for cognitive function.

Vitamin D

Vitamin D supplementation is increasingly promoted as important, particularly for the elderly, to build or maintain bone health and prevent fractures. But even when taken with calcium, the evidence for its effectiveness is not compelling.

A Cochrane review of research on vitamin D for the prevention of fractures in older people with osteoporosis identified 38 trials in which participants were randomly assigned to receive vitamin D supplements, placebo or no treatment. It concluded that:

Frail elderly people resident in nursing homes or residential care homes may suffer fewer hip and other non-vertebral fractures if they are given vitamin D with calcium supplements. The effectiveness of vitamin D alone in preventing fractures is unclear.

Vitamin D alone showed no clear effect on hip fracture in seven trials with a total of 18 668 participants, or on vertebral fracture in four trials with 5698 participants, or any new fracture in eight trials with 18 903 participants. Vitamin D taken with calcium was shown to reduce rates of both hip fracture (seven trials, 10 376 participants, RR = 0.8) and non-vertebral fracture (seven trials, 10 376 participants, RR = 0.9) only slightly when compared with placebo or no treatment.

A recently published United States Preventive Services Task Force (USPSTF) review concluded that daily supplementation with 400 international units (IU) or less of vitamin D and 1000 mg or less of calcium had no benefit for the primary prevention of fracture in community dwelling, postmenopausal women. The review also stated that the current evidence was insufficient to assess the balance of the benefits and harms of daily supplementation with higher doses of vitamin D and calcium. Moreover, the review found adequate evidence that supplementation with vitamin D and calcium increases the incidence of kidney stones. The USPSTF therefore now recommends against daily supplementation with 400 IU or less of vitamin D and 1000 mg or less of calcium for the primary prevention of fractures in community dwelling, postmenopausal women. (These recommendations do not apply to people with a history of osteoporotic fractures, increased risk for falls, osteoporosis or vitamin D deficiency.)

Folic acid

Women are given plenty of formal and informal advice about diet during pregnancy, and perhaps as a result are among the largest consumers of dietary supplements. A recent study of pregnant women in Sydney showed that 63 per cent of the sample reported taking a multivitamin and/or folic acid supplement in the three months prior to their pregnancy, and 94 per cent were taking at least one supplement during pregnancy.

Internationally consistent guidelines recommend that women take folic acid supplementation from when trying to conceive until 12 weeks of pregnancy, to reduce the occurrence of neural tube defects (NTDs) such as spina bifida and anencephaly (where the head (cephalic) end of the neural tube fails to close). A Cochrane Review of five trials involving 7391 women showed daily folic acid supplementation (alone or with other vitamins and minerals) was protective against NTDs compared with no intervention/ placebo or vitamins and minerals taken without folic acid (RR = 0.31, 95 per cent CI 0.17–0.58). Folic acid also had a significant protective effect for NTD recurrence (RR = 0.34, 95 per cent CI 0.18–0.64).

Vitamin B3

Australian researchers recently produced high-quality research evidence that nicotinamide (a form of vitamin B3) is protective against non-melanoma skin cancers (NMSCs).
NMSCs, which include basal-cell carcinoma and squamous-cell carcinoma, are principally due to skin damage from ultraviolet radiation and are common in light-skinned Australians.

The authors randomly assigned 386 participants who had had at least two NMSCs in the previous five years to receive 500 mg of nicotinamide twice daily or placebo for 12 months. Dermatologists evaluated all participants at three-monthly intervals for 18 months. At 12 months, the rate of new NMSCs was found to be 23 per cent lower (95 per cent CI 4–38) in the nicotinamide group than in the placebo group. In addition, the number of actinic keratoses (common precursors of NMSCs) was 13 per cent lower at 12 months. Numbers and types of adverse events did not differ between the groups.

Other researchers, in an update to the USPSTF review mentioned earlier (see Vitamin D section), evaluated the effect of another form of vitamin B3, niacin (nicotinic acid) on mortality. Niacin was once thought to prevent cardiovascular disease through its known ability to reduce cholesterol in the blood, and remains a common dietary supplement in Australia. Analysis of evidence from three trials showed that one to three grams per day of niacin in people taking statins (drugs commonly used to lower cholesterol levels) increased all-cause mortality by 10 per cent.

Supplement users versus non-users

Although much of the evidence above suggests that many common supplements have little or no effect – and others are potentially harmful – supplement users and non-users have significantly different health status. Research into supplement use in the Australian population confirmed that users were ‘more likely to participate in healthier lifestyle behaviours, have underlying diets that were higher in many nutrients and have a more favourable health status [than] supplement non-users’. Confirming other research, supplementation was more common among women than men, as well as in older adults, more highly educated people and people of high socio-economic status.

Conclusions

Cross-sectional research involving supplement users and non-users suggests that supplements promote good health, as the burgeoning complementary medicine industry claims. However, high-quality randomised trials have shown that while the most common supplements are useful in specific population groups – such as folate for pregnant women and nicotinamide for people at high risk of skin cancers – they have little or no effect for others, and in some cases are actually harmful. The fundamental message is that dietary supplements are unnecessary for most people able to eat a range of nutrient-rich whole foods.

  • About the author: Campbell Aitken
  • Dr Campbell Aitken is a freelance editor and a senior research fellow at the Burnet Institute.

If you would like to write an article for our Talking Points newsletter or In Brief blog, email Cassandra Hamilton (cassandrahamilton@westernalliance.org.au) or call 03 4215 2900.